S. No | RBP | Dataset (GEO ID) | Cell line | DEGs (up/down regulated) | Experiment (Knock-down/KD or knockout/KO) | Reference |
---|---|---|---|---|---|---|
1 | QKI | GSE153803 | C25Cl48 (muscular cell line) | None | siRNA KD, RNA-seq | [32] |
2 | ELAVL2 | GSE69092 | Primary neural progenitor cells | 0/3 | shRNA KD, RNA-seq | [33] |
3 | EIF2S1 | GSE80933 | HepG2 (human liver cancer cell line) | 2656/2748 | shRNA KD, RNA-seq | [34] |
 | GSE80900 | K562 (lymphoblasts) | 37/25 | shRNA KD, RNA-seq |  | |
4 | SRSF3 | GSE98016 | MDA-MB231 (epithelial cell line from breast cancer tissue) | 2909/3394 | shRNA KD, RNA-seq | [35] |
 | GSE130501 | Primary glioma stem-like cells (GSCs) | 257/180 | CRISPR KO, RNA-seq | [36] | |
 | GSE177820 | K562 (lymphoblasts) | 2277/1455 | CRISPR KO, RNA-seq | [34] | |
 | GSE71095 | HeLa cells | 36/2 | siRNA KD, RNA-seq | [37] | |
 | GSE71745 | A2780 (ovarian cancer cell line) | None | siRNA KD, microarray | [37] | |
5 | IGF2BP2 | GSE80946 | K562Â (lymphoblasts) | 1144/289 | shRNA KD, RNA-seq | [34] |
 | GSE80890 | HepG2 (human liver cancer cell line) | 1709/1926 | shRNA KD, RNA-seq |  | |
 | GSE146726 | UMUC3 (Bladder carcinoma) | 472/631 | siRNA KD, RNA-seq | [38] | |
 |  | J8 | 566/511 |  |  | |
6 | EIF4B | GSE177138 | HepG2 (human liver cancer cell line) | 9/7 | CRISPR KO, RNA-seq | [34] |
 | GSE80923 | K562 (lymphoblasts) | 20/43 | shRNA KD, RNA-seq |  | |
 | GSE80875 | HepG2 (human liver cancer cell line) | 2490/2474 |  |  | |
7 | SNRNP70 | GSE88425 | HepG2 (human liver cancer cell line) | 1960/1877 | shRNA KD, RNA-seq | Â |
8 | FMR1 | GSE177341 | K562Â (lymphoblasts) | 1346/1058 | shRNA KD, RNA-seq | Â |
 | GSE117248 | hiPSC-derived neurons | 2788/2864 | KO, RNA-seq | [39] | |
9 | DAZAP1 | GSE88637 | K562Â (lymphoblasts) | 261/51 | shRNA KD, RNA-seq | [34] |
 | GSE88114 | HepG2 (human liver cancer cell line) | 531/651 |  |  | |
 | GSE80929 | HepG2 (human liver cancer cell line) | 1450/1060 |  |  | |
 | GSE153803 | C25Cl48 (Muscular cell line) | None | siRNA KD, RNA-seq | [32] | |
 | GSE97262 | SH-SY5Y (neuroblastoma cell line) | 1684/3346 |  | [40] | |
10 | MBNL1 | GSE149435 | MDA-MB-231 (epithelial breast cancer cell line) | 673/693 | siRNA KD, RNA-seq | [41] |
 | GSE114383 | PC3 (Prostate cancer cell line) | 903/15 | Antisense oligonucleotide-mediated KD, RNA-seq | [42] | |
 | GSE41987 | HeLa | None | MBNL1-overexpression, microarray | - | |
 | GSE88116 | K562 (lymphoblasts) | 1467/527 | shRNA KD, RNA-seq | [34] | |
 | GSE76487 | MDA-MB-231(breast cancer cell line) | 0/6 | shRNA KD, RNA-seq | [43] | |
 | GSE153803 | C25Cl48 muscular cell line | None | siRNA KD, RNA-seq | [32] |